VALENCE LIFE SCIENCES
Valence Life Sciences is the only life sciences venture firm with a proven track record of success in late-stage investing. Our team has insight on what drives success from assessing management and clinical development plans for over 25 years.
VALENCE LIFE SCIENCES
Social Links:
Industry:
Angel Investment Life Science Venture Capital
Founded:
2012-01-01
Status:
Active
Contact:
(212) 521-4379
Technology used in webpage:
Amazon
Similar Organizations
BioAdvance
BioAdvance is a Pennsylvania-based venture capital firm that provides funding to life sciences startups.
CSC Upshot
CSC Upshot is an early stage venture fund focusing on providing seed capital to technology companies at scale.
JLS Fund
JLS Fund is a venture capital firm that invests in the psychedelics and technology intersection.
LifeSci Venture Partners
LifeSci Venture Partners is an early-stage investment firm that invests in early-stage life sciences and healthcare companies.
Nimble Partners
Nimble Partners is an investment management firm providing strategic advice and investments in early-stage companies.
Quaker BioVentures
Quaker BioVentures is a venture capital firm investing in life science companies. The firm leads investments across the spectrum of the
Ten Eleven Ventures
Ten Eleven Ventures is the original cybersecurity-focused, global, stage agnostic investment firm.
Founder
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2021-03-11 | CalciMedica | Valence Life Sciences investment in Series D - CalciMedica | 21 M USD |
| 2020-05-22 | CalciMedica | Valence Life Sciences investment in Series C - CalciMedica | 15 M USD |
| 2020-02-05 | JenaValve Technology | Valence Life Sciences investment in Venture Round - JenaValve Technology | 50 M USD |
| 2015-02-13 | Invuity | Valence Life Sciences investment in Private Equity Round - Invuity | 22.9 M USD |
| 2014-03-04 | Invuity | Valence Life Sciences investment in Series E - Invuity | 36 M USD |
| 2013-04-30 | Celator Pharmaceuticals | Valence Life Sciences investment in Private Equity Round - Celator Pharmaceuticals | 39.3 M USD |
| 2012-06-14 | Invuity | Valence Life Sciences investment in Series D - Invuity | 25 M USD |
| 2012-01-09 | Invuity | Valence Life Sciences investment in Venture Round - Invuity | 2 M USD |
More informations about "Valence Life Sciences"
Valence Life Sciences
Valence Life Sciences is the only life sciences venture firm with a proven record of success in late-stage investing. Our experienced team draws on over 25 years of expertise.See details»
Valence Life Sciences - Crunchbase Investor Profile & Investments
Valence Life Sciences is the only life sciences venture firm with a proven track record of success in late-stage investing. Our team has insight on what drives success from assessing …See details»
Valence Life Sciences
Learn more about our Founding Managing Directors: A. Rachel Leheny, PhD, and Eric W. Roberts. A. Rachel Leheny, PhD, and Eric W. Roberts.See details»
Valence Life Sciences - Investments, Portfolio & Company Exits
Valence Life Sciences is the only life sciences venture firm with a proven track record of success in late-stage investing.See details»
Valence Life Sciences
A private company rapidly advancing transformative therapies for patients with life threatening viral diseases. calcimedica A public company developing novel drugs for inflammatory and …See details»
Valence Life Sciences - Funding, Financials, Valuation & Investors
Valence Life Sciences is the only life sciences venture firm with a proven track record of success in late-stage investing.See details»
Valence Life Sciences investment portfolio | PitchBook
Jun 15, 2015 · Information on investments, active portfolio, exits, fund performance, dry powder, and co-investors for Valence Life Sciences. Use the PitchBook Platform to explore the full profile.See details»
Valence Life Sciences - Massinvestor Venture Capital and Private …
Valence Life Sciences is a leading life sciences investment firm focused on late-stage private and micro-cap public drug development companies.See details»
Valence Life Sciences - LinkedIn
The only life sciences venture firm with a proven track record of success in late-stage investing. | Valence Life Sciences is a biotech venture capital fund based out of 500 Park Avenue, New...See details»
Valence Life Sciences - Private Equity Firm Profile - Gaebler.com ...
Valence Life Sciences is a New York- and San Diego-based life sciences venture capital firm founded by Dr. Rachel Leheny and Eric Roberts to focus on clinical development stage private …See details»
Valence Life Sciences - CB Insights
Valence Life Sciences is a leading life sciences investment firm focused on late-stage private and micro-cap public drug development companies. Use the CB Insights Platform to explore …See details»
Valence Life Sciences - Contacts, Employees, Board Members
Valence Life Sciences is the only life sciences venture firm with a proven track record of success in late-stage investing.See details»
Eric Roberts - Managing Director and Founder - Valence Life …
Managing Director, Valence Life Sciences · Experience: Valence Life Sciences · Location: New York · 280 connections on LinkedIn. View Eric Roberts’ profile on LinkedIn, a professional...See details»
Valence Life Sciences
Dr. Leheny has 30 years of experience in the life sciences industry. From April 2000 to May of 2002, Dr. Leheny was the Head of the Biotechnology Research Team and a Senior Vice …See details»
Valence: creating a world-leading AI chemistry design company
Dec 15, 2021 · AI is an increasingly important tool for life sciences and a significant part of our targeted investing area. Valence, who is developing a strong AI platform, is a great example of …See details»
Charles River Laboratories signs AI pact with Valence Discovery to ...
Apr 6, 2021 · Early-stage contract research organization Charles River Labs is delving deeper into artificial intelligence with a new pact inked this week with Valence Discovery.See details»
Valence Life Sciences - Crunchbase
Valence Life Sciences is the only life sciences venture firm with a proven track record of success in late-stage investing.See details»
Valence Life Sciences
CalciMedica Raises $15 Million in Series C Financing Round Led by Valence Life SciencesSee details»
Valence Life Sciences
Roberts was also a Managing Director, Partner and founder of the Life Sciences Department at Dillon, Read & Co. Inc. which was ultimately merged into UBS. At UBS, Mr. Roberts ran the …See details»
Valence Discovery - Crunchbase Company Profile & Funding
Valence Discovery (“Valence”), is an AI-first design of novel chemistry against previously intractable biology. Valence Discovery may be growing as evidenced by its recent acquisition …See details»